Emerging Insights on Adverse Events During ART and Implications for Treatment

Download All
In this comprehensive online program led by expert faculty, review clinical strategies for applying the latest safety and tolerability data when selecting or modifying individualized ART regimens for patients with HIV infection.
Joseph J. Eron, Jr., MD
Darcy Wooten, MD

Video Module

Watch this dynamic faculty discussion on the impact of emerging ART safety and tolerability data on ART initiation and switch strategies.

Joseph J. Eron, Jr., MD Darcy Wooten, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 11, 2021 Expired: May 10, 2022

Gain expert insight on the impact of emerging ART safety and tolerability data on ART initiation and switch strategies.

Joseph J. Eron, Jr., MD Darcy Wooten, MD Released: May 11, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue